Alvotech and Advanz Pharma have submitted a European marketing application for their golimumab biosimilar to treat ...

Prolia, a brand of the drug denosumab, is a monoclonal antibody that can also be used to treat osteoporosis. Prolia works ...

Patents for denosumab expired in some European markets in June, although the drug is still protected in France, Italy, Spain, and the UK until 2025, when exclusivity also comes to an end in the US ...

Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.

Amgen sells RANKL inhibitor denosumab as Prolia for osteoporosis in women and men and bone loss caused by other drug treatments, while Xgeva is used for a range of cancer indications, including ...

Tiffany May, 59, was hiking alone in the Adelaide Hills last year when she fell and lost consciousness. When she came to, she was in intense pain and suspected she'd broken her hip. Hospital scans ...

FDA’s boxed warning on denosumab follows study results showing increased and early risks of severe hypocalcemia in patients on dialysis. The Food and Drug Administration (FDA) has added a new ...